Abstract:Background: Portosystemic shunts (PSS) are abnormal vascular connections between the portal vein or its tributaries and the systemic vein that allow mesenteric blood to reach the systemic circulation without first passing through the liver. PSS can be associated with various syndromes and can lead to serious complications. We report a rare case of a child with PSS and recurrent hypoglycaemia. Case: A 20-month-old girl with Down's syndrome presented with recurrent hypoglycaemic episodes. She had multiple anomal… Show more
“…The authors described these effects as a result of reduced insulin degradation in the liver [ 6 ]. This effect has also been described in a few other case reports [ 9 , 10 ]. Bas et al postulated an insufficient postprandial hepatic glucose uptake, resulting in early systemic hyperglycemia, leading to an exaggerated insulin secretion [ 9 ].…”
BackgroundCongenital portosystemic shunts present with various associated complications, such as other congenital malformations, hyperammonemia, or hepatopulmonary syndrome. Few cases of associated hypoglycemia have been reported so far and our case, to the best of our knowledge, describes the most severe extent of hypoglycemia.Case presentationWe describe the case of a newborn Arab boy with two intrahepatic portosystemic shunts, resulting in severe and persistent hypoglycemia, due to which one of the shunts was closed by interventional radiology whereas the other shunt had already closed spontaneously.ConclusionsBecause he showed elevated levels for insulin and prolonged high insulin levels in an oral glucose tolerance test, our case supports the theory that portocaval shunts cause a reduced hepatic insulin reduction due to the high blood volume bypassing the liver. This case provides further insights into glucose regulation mechanisms of the liver and we suggest a consistent screening for hypoglycemia in patients with congenital portosystemic shunts.
“…The authors described these effects as a result of reduced insulin degradation in the liver [ 6 ]. This effect has also been described in a few other case reports [ 9 , 10 ]. Bas et al postulated an insufficient postprandial hepatic glucose uptake, resulting in early systemic hyperglycemia, leading to an exaggerated insulin secretion [ 9 ].…”
BackgroundCongenital portosystemic shunts present with various associated complications, such as other congenital malformations, hyperammonemia, or hepatopulmonary syndrome. Few cases of associated hypoglycemia have been reported so far and our case, to the best of our knowledge, describes the most severe extent of hypoglycemia.Case presentationWe describe the case of a newborn Arab boy with two intrahepatic portosystemic shunts, resulting in severe and persistent hypoglycemia, due to which one of the shunts was closed by interventional radiology whereas the other shunt had already closed spontaneously.ConclusionsBecause he showed elevated levels for insulin and prolonged high insulin levels in an oral glucose tolerance test, our case supports the theory that portocaval shunts cause a reduced hepatic insulin reduction due to the high blood volume bypassing the liver. This case provides further insights into glucose regulation mechanisms of the liver and we suggest a consistent screening for hypoglycemia in patients with congenital portosystemic shunts.
“…The clinical presentations of CEPS may vary and depend on associated conditions: (1) liver dysfunction and hepatic neoplasms, which may be benign (focal nodular hyperplasia and nodular regenerative hyperplasia) or malignant (liver cancer), may be due to the lack of perfusion and nutrient delivery to the liver [9–11]. (2) Congenital hepatic shunts can also present together with hepatic encephalopathy, hepatopulmonary syndrome [12], and hypoglycaemia [13]. (3) Increased pressure of the splenic vein and superior mesenteric vein system with complete or partial occlusion of the portal vein can lead to hypersplenism and haemorrhage of the digestive tract.…”
Background
Congenital extrahepatic portocaval shunt (CEPS), also known as Abernethy malformation, is an extremely rare anomaly of the splanchnic venous system, especially when accompanied by pulmonary arterial hypertension.
Case presentation
We report a case of a 15-year-old female who was diagnosed with CEPS (Abernethy type Ib) accompanied by pulmonary arterial hypertension. This case was incidentally identified during abdominal ultrasound examination and confirmed by mesenteric and splenic arteriography. During more than 4 years of follow-up, after receiving sildenafil (80 mg/day), the patient’s condition improved in the first year after discharge. However, one year later, the patient’s conditions start to deteriorate.
Conclusion
This article presents a rare case of Abernethy malformation accompanied by pulmonary arterial hypertension, which can be diagnosed by using abdominal ultrasonography, portal vein computed tomography angiography or mesenteric and splenic arteriography. This malformation had limited treatment and poor prognosis.
“…6,7 Hence, it is possible that patients with CPSS have high insulin concentration, especially after meals, because insulin secreted from beta cells flows directly into the systemic circulation. Senniappan et al 4 reported on a 20-month-old girl with CPSS who had hyperinsulinemic hypoglycemia. The hypoglycemia was completely cured after surgical closure of the shunt, and OGTT after surgery showed no hyperinsulinemia.…”
Section: Discussionmentioning
confidence: 99%
“…Some CPSS patients also have hypoglycemia. Recently, Senniappan et al 4 reported on the case of a 20-month-old girl with Down syndrome and CPSS who presented with hyperinsulinemic hypoglycemia, possibly due to lack of insulin degradation in the liver. Herein we describe the case of a 5-month-old boy with post-prandial CHH and type 1 extrahepatic CPSS.…”
Congenital hyperinsulinemic hypoglycemia (CHH) is characterized by the inappropriate secretion of insulin from pancreatic beta cells in the presence of hypoglycemia. We herein describe the case of a 5-month-old boy with CHH due to congenital portosystemic shunt (CPSS). Insulin secreted from pancreatic beta cells flows into the portal vein and is first metabolized in the liver. First-pass elimination of insulin in the liver leads to great decrease in insulin concentration by approximately 40-80% in humans. CPSS accounts for a large quantity of insulin delivery into the systemic circulation due to the lack of hepatic first-pass elimination. Hypoglycemia can result from consistently high levels of insulin after reaching normal glucose level. CPSS therefore should be considered as a rare cause of CHH, especially in the case of post-prandial hyperinsulinemic hypoglycemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.